BIOCRYST PHARMACEUTICALS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIOCRYST PHARMACEUTICALS, INC. treasury stock, shares, acquired for fiscal 2011 was 12.00K shares, a 1100.00% increase from fiscal 2010.
- BIOCRYST PHARMACEUTICALS, INC. treasury stock, shares, acquired for fiscal 2010 was 1.00K shares, a 95.83% decline from fiscal 2009.
- BIOCRYST PHARMACEUTICALS, INC. treasury stock, shares, acquired for fiscal 2009 was 24.00K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2011-12-31 | 12.00K shares 10-K · filed 2014-03-10 | |
| 2010-12-31 | 1.00K shares 10-K · filed 2013-03-11 | |
| 2009-12-31 | 24.00K shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |